United Kingdom · Question · Written question
HL HL11894
Blood Cancer: Coronavirus
Introduced
7 January 2021
Last action
23 April 2021 · Answer
Status
Answered
Sponsors
—
Subjects
Discovery layer
Source updated
23 April 2021
Summary
To ask Her Majesty's Government what assessment they have made of (1) the risks to, and (2) the most effective treatment and vaccination options for, blood cancer patients in relation to COVID-19; and what discussions they have had with health agencies on
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
7 January 2021
Written question
To ask Her Majesty's Government what assessment they have made of (1) the risks to, and (2) the most effective treatment and vaccination options for, blood cancer patients in relation to COVID-19; and what discussions they have had with health agencies on
Source: Lords
23 April 2021
Answer
Patients with blood cancer are included in the Joint Committee on Vaccination and Immunisation’s priority group four, for individuals who are clinically extremely vulnerable to COVID-19. Patients with blood cancer outside of these diagnoses would be inclu...
Source: Written answer
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
- · Department of Health and Social Care · Answering body
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://questions-statements.parliament.uk/written-questions/detail/2021-01-07/HL11894
- Open data entity: https://questions-statements-api.parliament.uk/api/writtenquestions/questions/1274596
- uk · wq-1274596 · source updated 23 April 2021